ALTIMMUNE, INC. Debt Instrument, Interest Rate During Period
ALTIMMUNE, INC. (ALT) reported Debt Instrument, Interest Rate During Period of 6.50% for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2012-11-06
- 2012-09-30: Debt Instrument, Interest Rate During Period 9 month 6.50%.
- 2012-06-30: Debt Instrument, Interest Rate During Period 6 month 6.50%.
| Period end | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month |
|---|---|---|
| 2012-09-30 | 6.50% 10-Q · filed 2012-11-06 | |
| 2012-06-30 | 6.50% 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |